141 related articles for article (PubMed ID: 12866970)
1. [Clinicopathological characteristics of primary nasopharyngeal adenocarcinoma].
He JH; Zong YS; Luo RZ; Liang XM; Wu QL; Liang YJ
Ai Zheng; 2003 Jul; 22(7):753-7. PubMed ID: 12866970
[TBL] [Abstract][Full Text] [Related]
2. A retrospective cohort study of nasopharyngeal adenocarcinoma: a rare histological type of nasopharyngeal cancer.
Guo ZM; Liu WW; He JH
Clin Otolaryngol; 2009 Aug; 34(4):322-7. PubMed ID: 19673979
[TBL] [Abstract][Full Text] [Related]
3. Nasopharyngeal adenocarcinomas: a clinicopathologic study of 44 cases including immunohistochemical features of 18 papillary phenotypes.
Pineda-Daboin K; Neto A; Ochoa-Perez V; Luna MA
Ann Diagn Pathol; 2006 Aug; 10(4):215-21. PubMed ID: 16844563
[TBL] [Abstract][Full Text] [Related]
4. Spreading patterns, prognostic factors and treatment outcomes of nasopharyngeal papillary adenocarcinoma and salivary gland-type carcinomas.
Liu LZ; Zhang YM; Chen Y; Li L
Clin Otolaryngol; 2016 Apr; 41(2):160-8. PubMed ID: 26118586
[TBL] [Abstract][Full Text] [Related]
5. [Clinical staging of nasopharyngeal carcinoma based on MRI: suggestions for improving the Chinese '92 staging system].
Mao YP; Hong MH; Sun Y; Liang SB; Li L; Liu LZ; Tang LL; Cao SM; Lin AH; Lu TX; Liu MZ; Ma J
Ai Zheng; 2007 Oct; 26(10):1099-106. PubMed ID: 17927881
[TBL] [Abstract][Full Text] [Related]
6. Different therapeutic strategies in primary salivary gland-type nasopharyngeal carcinomas.
Liu TR; Chen FJ; Zhang GP; Yang AK
Curr Opin Otolaryngol Head Neck Surg; 2011 Apr; 19(2):87-91. PubMed ID: 21297475
[TBL] [Abstract][Full Text] [Related]
7. Association of E-cadherin and beta-catenin with metastasis in nasopharyngeal carcinoma.
Li Z; Ren Y; Lin SX; Liang YJ; Liang HZ
Chin Med J (Engl); 2004 Aug; 117(8):1232-9. PubMed ID: 15361301
[TBL] [Abstract][Full Text] [Related]
8. High incidence of lymph node metastasis in major salivary gland cancer.
Stennert E; Kisner D; Jungehuelsing M; Guntinas-Lichius O; Schröder U; Eckel HE; Klussmann JP
Arch Otolaryngol Head Neck Surg; 2003 Jul; 129(7):720-3. PubMed ID: 12874071
[TBL] [Abstract][Full Text] [Related]
9. Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma.
Lu TX; Mai WY; Teh BS; Zhao C; Han F; Huang Y; Deng XW; Lu LX; Huang SM; Zeng ZF; Lin CG; Lu HH; Chiu JK; Carpenter LS; Grant WH; Woo SY; Cui NJ; Butler EB
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):682-7. PubMed ID: 14967420
[TBL] [Abstract][Full Text] [Related]
10. [Clinical analysis of orbital metastasis from nasopharyngeal carcinoma].
Zhang H; Yan JH; Wu ZY; Li YP
Zhonghua Yan Ke Za Zhi; 2006 Apr; 42(4):318-22. PubMed ID: 16762208
[TBL] [Abstract][Full Text] [Related]
11. [Staging 915 cases of nasopharyngeal carcinoma after simple radical radiotherapy--checkout of Fuzhou staging system (1992)].
Gao JM; Zeng YX; Cui NJ; Lu TX; Zhao C; Xia YF; Ma J; Xie FY
Ai Zheng; 2005 Oct; 24(10):1165-72. PubMed ID: 16219127
[TBL] [Abstract][Full Text] [Related]
12. Primary salivary gland-type lung cancer: spectrum of clinical presentation, histopathologic and prognostic factors.
Molina JR; Aubry MC; Lewis JE; Wampfler JA; Williams BA; Midthun DE; Yang P; Cassivi SD
Cancer; 2007 Nov; 110(10):2253-9. PubMed ID: 17918258
[TBL] [Abstract][Full Text] [Related]
13. Loss of Maspin expression is a negative prognostic factor in common salivary gland tumors.
Schwarz S; Ettl T; Kleinsasser N; Hartmann A; Reichert TE; Driemel O
Oral Oncol; 2008 Jun; 44(6):563-70. PubMed ID: 17936671
[TBL] [Abstract][Full Text] [Related]
14. [Irradiation field design according to locoregional relapse sites after radiotherapy of nasopharyngeal carcinoma].
Luo W; Tang YQ; Huang Y; Lu LX; Lu TX
Ai Zheng; 2006 Feb; 25(2):209-11. PubMed ID: 16480588
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor receptor immunoexpression evaluation in malignant salivary gland tumours.
Monteiro LS; Bento MJ; Palmeira C; Lopes C
J Oral Pathol Med; 2009 Jul; 38(6):508-13. PubMed ID: 19317849
[TBL] [Abstract][Full Text] [Related]
16. Nasopharyngeal cancer in the Middle East: experience of the American University of Beirut Medical Center.
Geara FB; Nasr E; Tucker SL; Brihi E; Zaytoun G; Hadi U; Salem Z; El Saghir N; Issa P; Shamseddine A
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1408-15. PubMed ID: 15817344
[TBL] [Abstract][Full Text] [Related]
17. Dedifferentiated adenoid cystic carcinoma: a clinicopathologic study of 6 cases.
Nagao T; Gaffey TA; Serizawa H; Sugano I; Ishida Y; Yamazaki K; Tokashiki R; Yoshida T; Minato H; Kay PA; Lewis JE
Mod Pathol; 2003 Dec; 16(12):1265-72. PubMed ID: 14681328
[TBL] [Abstract][Full Text] [Related]
18. Lip cancer experience in Mexico. An 11-year retrospective study.
Luna-Ortiz K; Güemes-Meza A; Villavicencio-Valencia V; Mosqueda-Taylor A
Oral Oncol; 2004 Nov; 40(10):992-9. PubMed ID: 15509490
[TBL] [Abstract][Full Text] [Related]
19. Intraoral minor salivary gland tumors: a clinicopathological study of 82 cases.
Toida M; Shimokawa K; Makita H; Kato K; Kobayashi A; Kusunoki Y; Hatakeyama D; Fujitsuka H; Yamashita T; Shibata T
Int J Oral Maxillofac Surg; 2005 Jul; 34(5):528-32. PubMed ID: 16053873
[TBL] [Abstract][Full Text] [Related]
20. High rate of lymph-node metastasis in submucosal esophageal squamous-cell carcinomas and adenocarcinomas.
Bollschweiler E; Baldus SE; Schröder W; Prenzel K; Gutschow C; Schneider PM; Hölscher AH
Endoscopy; 2006 Feb; 38(2):149-56. PubMed ID: 16479422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
